FI45047C - Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi. - Google Patents
Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi.Info
- Publication number
- FI45047C FI45047C FI631219A FI121963A FI45047C FI 45047 C FI45047 C FI 45047C FI 631219 A FI631219 A FI 631219A FI 121963 A FI121963 A FI 121963A FI 45047 C FI45047 C FI 45047C
- Authority
- FI
- Finland
- Prior art keywords
- sulphanilamido
- methoxypyrimidine
- preparation
- therapeutically useful
- therapeutically
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02M—APPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER; CONTROL OR REGULATION THEREOF
- H02M7/00—Conversion of ac power input into dc power output; Conversion of dc power input into ac power output
- H02M7/42—Conversion of dc power input into ac power output without possibility of reversal
- H02M7/44—Conversion of dc power input into ac power output without possibility of reversal by static converters
- H02M7/48—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode
- H02M7/53—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal
- H02M7/537—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal using semiconductor devices only, e.g. single switched pulse inverters
- H02M7/538—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal using semiconductor devices only, e.g. single switched pulse inverters in a push-pull configuration
- H02M7/5381—Parallel type
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02M—APPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER; CONTROL OR REGULATION THEREOF
- H02M7/00—Conversion of ac power input into dc power output; Conversion of dc power input into ac power output
- H02M7/02—Conversion of ac power input into dc power output without possibility of reversal
- H02M7/04—Conversion of ac power input into dc power output without possibility of reversal by static converters
- H02M7/06—Conversion of ac power input into dc power output without possibility of reversal by static converters using discharge tubes without control electrode or semiconductor devices without control electrode
- H02M7/068—Conversion of ac power input into dc power output without possibility of reversal by static converters using discharge tubes without control electrode or semiconductor devices without control electrode mounted on a transformer
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02M—APPARATUS FOR CONVERSION BETWEEN AC AND AC, BETWEEN AC AND DC, OR BETWEEN DC AND DC, AND FOR USE WITH MAINS OR SIMILAR POWER SUPPLY SYSTEMS; CONVERSION OF DC OR AC INPUT POWER INTO SURGE OUTPUT POWER; CONTROL OR REGULATION THEREOF
- H02M7/00—Conversion of ac power input into dc power output; Conversion of dc power input into ac power output
- H02M7/42—Conversion of dc power input into ac power output without possibility of reversal
- H02M7/44—Conversion of dc power input into ac power output without possibility of reversal by static converters
- H02M7/48—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode
- H02M7/53—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal
- H02M7/537—Conversion of dc power input into ac power output without possibility of reversal by static converters using discharge tubes with control electrode or semiconductor devices with control electrode using devices of a triode or transistor type requiring continuous application of a control signal using semiconductor devices only, e.g. single switched pulse inverters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Power Engineering (AREA)
- Cephalosporin Compounds (AREA)
- Inverter Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS368362 | 1962-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI45047B FI45047B (fi) | 1971-11-30 |
FI45047C true FI45047C (fi) | 1972-03-10 |
Family
ID=5377609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI631219A FI45047C (fi) | 1962-06-15 | 1963-06-14 | Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi. |
Country Status (10)
Country | Link |
---|---|
US (1) | US3302096A (fi) |
AT (1) | AT242149B (fi) |
BE (1) | BE633513A (fi) |
CH (1) | CH428742A (fi) |
DK (1) | DK113647B (fi) |
ES (1) | ES289042A1 (fi) |
FI (1) | FI45047C (fi) |
FR (1) | FR1365535A (fi) |
GB (1) | GB993295A (fi) |
NL (2) | NL294097A (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4301499A (en) * | 1980-06-13 | 1981-11-17 | The United States Of America As Represented By The Secretary Of The Army | Inverter circuit with current equalization |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2516563A (en) * | 1948-04-19 | 1950-07-25 | Gen Electric | Magnetic amplifier for inductive loads |
US2774878A (en) * | 1955-08-29 | 1956-12-18 | Honeywell Regulator Co | Oscillators |
US2883539A (en) * | 1956-06-14 | 1959-04-21 | Avco Mfg Corp | Transverter |
GB909969A (fi) * | 1958-07-26 |
-
0
- NL NL291120D patent/NL291120A/xx unknown
- BE BE633513D patent/BE633513A/xx unknown
- NL NL294097D patent/NL294097A/xx unknown
-
1962
- 1962-10-12 US US230211A patent/US3302096A/en not_active Expired - Lifetime
-
1963
- 1963-05-31 FR FR936838A patent/FR1365535A/fr not_active Expired
- 1963-06-13 CH CH737263A patent/CH428742A/de unknown
- 1963-06-14 DK DK281663AA patent/DK113647B/da unknown
- 1963-06-14 GB GB23807/63A patent/GB993295A/en not_active Expired
- 1963-06-14 FI FI631219A patent/FI45047C/fi active
- 1963-06-14 ES ES289042A patent/ES289042A1/es not_active Expired
- 1963-06-14 AT AT480863A patent/AT242149B/de active
Also Published As
Publication number | Publication date |
---|---|
NL291120A (fi) | 1900-01-01 |
BE633513A (fi) | 1900-01-01 |
AT242149B (de) | 1965-08-25 |
CH428742A (de) | 1967-01-31 |
US3302096A (en) | 1967-01-31 |
FR1365535A (fr) | 1964-07-03 |
DK113647B (da) | 1969-04-14 |
GB993295A (en) | 1965-05-26 |
FI45047B (fi) | 1971-11-30 |
ES289042A1 (es) | 1963-11-01 |
NL294097A (fi) | 1900-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI42564C (fi) | Menetelmä valmistaa terapeuttisesti vaikuttavia 2-aryyliamino-1,3-diatsasykloalkeeneja | |
FI45970C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. | |
DK104675C (da) | Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid. | |
SE300618B (sv) | Förfarande för framställning av N-fenylpropyl- N1 -fenylpiperaziner | |
FI46069C (fi) | Menetelmä terapeuttisesti käytettävän 1-R-2-formyyli-5-nitroimidatsoli n valmistamiseksi. | |
CH449670A (de) | Kopierverfahren | |
FI46373C (fi) | Menetelmä fenyyliaminopropaanin uusien terapeuttisesti käyttökelpoiste n johdannaisten valmistamiseksi. | |
FI41965C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien diaralkyyliamiinien valmistamiseksi | |
FI45180C (fi) | Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi. | |
FI46507C (fi) | Menetelmä uuden terapeuttisesti käytettävän 1-metyyli-N-karbobentsoksi dihydrolysergamiinin valmistamiseksi. | |
FI45047C (fi) | Menetelmä terapeuttisesti käytettävän 2-sulfaniiliamido-5-metoksipyrim idiinin valmistamiseksi. | |
DK108015C (da) | Fremgangsmåde til fremstilling af et bakteriepræparat. | |
CH425752A (it) | Procedimento per la preparazione di cicloesilfenilchetone | |
DK103476C (da) | Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider. | |
FI43994C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi | |
DK103512C (da) | Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon. | |
FI36530A (fi) | Menetelmä 3-fenoksipropyyliguanidiinin valmistamiseksi | |
FI41400C (fi) | Menetelmä uusien terapeuttisesti arvokkaiden pyrrodiliiniyhdisteiden valmistamiseksi | |
FI34517A (fi) | 5-pyratsolyylialkamiinieetterien valmistusmenetelmä | |
CH419961A (de) | Fertigungsstrasse | |
DK104063C (da) | Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner. | |
IS1260A7 (is) | Aðferð til framleiðslu 6-desoxy-6-desmethyltetracyclin. | |
FI35478A (fi) | Menetelmä terapeuttisesti tehokkaan 17beta-hydroksi-17alfa-metyyli-androstaani-(3,2-c)-iso-oksatsolin valmistamiseksi | |
FI46729C (fi) | Menetelmä uusien, terapeuttisesti käytettävien karboksiamidoalkyyli-1, 3-bentsoksatsiinien valmistamiseksi | |
FI46726C (fi) | Menetelmä uusien terapeuttisesti käytettävien nor-3alfa- tai 3beta-tro panolin atsoniaspiraanien tai niiden estereiden valmistamiseksi. |